More than 500 small nucleotide polymorphisms (SNPs) are associated with MS risk, involving mostly immune associated genes, such as IL-2 receptor subunit alpha (IL2RA), IL7R, CLEC16A and CD226 (5). The gene discussed is CLEC16A; the disease is myeloid sarcoma.